Journal of Clinical Endocrinology & Metabolism, Vol 81, 4002-4006, Copyright © 1996 by Endocrine Society

ARTICLES

Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys

TA Molskness, TK Woodruff, DL Hess, KD Dahl and RL Stouffer
Division of Reproductive Sciences, Oregon Regional Primate Research Center 97006, USA.

Inhibin, a suppressor of pituitary FSH secretion in nonprimate species, may also act in the ovary to regulate follicular development. To examine whether inhibin has similar actions in primates, female rhesus monkeys (n = 3/treatment), exhibiting regular menstrual cycles, received sc injections of either vehicle or 60 micrograms/kg recombinant human inhibin-A at 0800 and 1600 h for 5 days beginning at menses. The vehicle-treated monkeys displayed menstrual cycles of normal length, with the follicular (11.3 +/- 2.5 days, mean +/- SE) and luteal (16.3 +/- 2.5 days) phases demarcated by midcycle peaks in serum estradiol (E) and bioactive LH. After the first inhibin injection, levels of immunoreactive inhibin A peaked at 10 ng/mL within 1 h and returned to baseline (< 0.1 ng/mL) before the second injection 8 h later. Although serum E and LH did not change, bioactive FSH decreased (to 66% of pretreatment levels, P < 0.05) within 8 h. Within 1 day, circulating bioactive FSH was less (P < 0.05) in inhibin-treated monkeys, compared with controls. By 2-3 days, serum E levels were also markedly (P < 0.05) reduced in inhibin-treated animals, whereas bioactive LH rose 3-fold (P < 0.05). After inhibin treatment, the midcycle rises in serum E and LH were delayed; hence, the follicular phase was prolonged (15.0 +/- 2.6 days, P < 0.05), compared with controls. Although the patterns and levels of serum LH circulating during the subsequent luteal phase seemed comparable in both groups, mean progesterone levels were suppressed to 2-3 ng/mL (P < 0.05) during the midluteal phase in inhibin-treated monkeys. However, the length of the luteal phase in inhibin-treated cycles (13.0 +/- 2.6 days) was not significantly altered. We conclude that exogenous inhibin rapidly diminishes pituitary FSH secretion in female monkeys during the early follicular phase of the menstrual cycle. This action, and/or other actions directly on the ovary, leads to subsequent effects on follicular steroidogenesis and pituitary LH secretion that culminate in an aberrant ovarian cycle characterized by an insufficient luteal phase. The study identifies, for the first time, possible activities and roles of inhibin during the ovarian cycle in primates.

This article has been cited by other articles:

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]

				F. P Hohmann, J. S E Laven, F. H de Jong, and B. C J M Fauser Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women Eur. J. Endocrinol., March 1, 2005; 152(3): 395 - 401. [Abstract] [Full Text] [PDF]

				S. Luisi, P. Florio, F. M. Reis, and F. Petraglia Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy Hum. Reprod. Update, March 1, 2005; 11(2): 123 - 135. [Abstract] [Full Text] [PDF]

				C. K. Welt, J. E. Hall, J. M. Adams, and A. E. Taylor Relationship of Estradiol and Inhibin to the Follicle-Stimulating Hormone Variability in Hypergonadotropic Hypogonadism or Premature Ovarian Failure J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 826 - 830. [Abstract] [Full Text] [PDF]

				F. Miro and L.J. Aspinall The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle Hum. Reprod., January 1, 2005; 20(1): 96 - 100. [Abstract] [Full Text] [PDF]

				K. Dafopoulos, C.G. Kotsovassilis, S. Milingos, A. Kallitsaris, G. Galazios, E. Zintzaras, P. Sotiros, and I.E. Messinis Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role Hum. Reprod., September 1, 2004; 19(9): 1985 - 1992. [Abstract] [Full Text] [PDF]

				K. A. Young, C. L. Chaffin, T. A. Molskness, and R. L. Stouffer Controlled ovulation of the dominant follicle: a critical role for LH in the late follicular phase of the menstrual cycle Hum. Reprod., November 1, 2003; 18(11): 2257 - 2263. [Abstract] [Full Text] [PDF]

				C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771. [Abstract] [Full Text] [PDF]

				C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]

				I. E. Messinis, S. Milingos, E. Alexandris, I. Mademtzis, G. Kollios, and K. Seferiadis Evidence of differential control of FSH and LH responses to GnRH by ovarian steroids in the luteal phase of the cycle Hum. Reprod., February 1, 2002; 17(2): 299 - 303. [Abstract] [Full Text] [PDF]

				A.L. Mikkelsen, A.-M. Andersson, N.E. Skakkebak, and S. Lindenberg Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women Hum. Reprod., May 1, 2001; 16(5): 862 - 867. [Abstract] [Full Text] [PDF]

				T. M. Pierson, Y. Wang, F. J. DeMayo, M. M. Matzuk, S. Y. Tsai, and B. W. O’Malley Regulable Expression of Inhibin A in Wild-Type and Inhibin {alpha} Null Mice Mol. Endocrinol., July 1, 2000; 14(7): 1075 - 1085. [Abstract] [Full Text]

				N. Lahlou, N. Chabbert-Buffet, S. Christin-Maitre, E. Le Nestour, M. Roger, and P. Bouchard Main inhibitor of follicle stimulating hormone in the luteal–follicular transition: inhibin A, oestradiol, or inhibin B? Hum. Reprod., May 1, 1999; 14(5): 1190 - 1193. [Abstract] [Full Text] [PDF]

				H. M. Fraser, N. P. Groome, and A. S. McNeilly Follicle-Stimulating Hormone-Inhibin B Interactions during the Follicular Phase of the Primate Menstrual Cycle Revealed by Gonadotropin-Releasing Hormone Antagonist and Antiestrogen Treatment J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1365 - 1369. [Abstract] [Full Text]

				J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF]

				T. K. Woodruff Editorial: Hope, Hypothesis, and the Inhibin Receptor. Does Specific Inhibin Binding Suggest There Is a Specific Inhibin Receptor? Endocrinology, January 1, 1999; 140(1): 3 - 5. [Full Text]

				S. Ramaswamy, C. R. Pohl, A. S. McNeilly, S. J. Winters, and T. M. Plant The Time Course of Follicle-Stimulating Hormone Suppression by Recombinant Human Inhibin A in the Adult Male Rhesus Monkey (Macaca mulatta) Endocrinology, August 1, 1998; 139(8): 3409 - 3415. [Abstract] [Full Text] [PDF]

				C. K. Welt, K. A. Martin, A. E. Taylor, G. M. Lambert-Messerlian, W. F. Crowley Jr., J. A. Smith, D. A. Schoenfeld, and J. E. Hall Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2645 - 2652. [Abstract] [Full Text] [PDF]